Centre for Commercialization of Regenerative Medicine Investments

Centre for Commercialization of Regenerative Medicine has invested in 1 company and its latest investment was Notch Therapeutics on Feb 09, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Notch Therapeutics is a British Columbia-based biotechnology company that develops and commercializes T cell therapeutics for the treatment of cancer.
$85M
Feb 09, 2021
-